Ribociclib has become a commonly used treatment for ER-positive, HER2-negative breast cancer that requires treatment beyond surgery and radiation therapy. Â It is a targeted therapy called a CDK4/6 inhibitor that shuts down certain processes that...
Ribociclib has become a commonly used treatment for ER-positive, HER2-negative breast cancer  that requires treatment beyond surgery and radiation therapy. It is a targeted therapy called a CDK4/6 inhibitor that shuts down certain processes that...